Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 9/20 | 0.51 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.51 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.51 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15533205 | 0.98 | FDPS (0.53) | FDPSBTN3A1PDE3AKCNA5CYP19A1 | |
| SCHEMBL9219072 | 0.81 | FDPS (0.47) | FDPSBTN3A1PDE3AKCNA5CYP19A1 | |
| L-Arabinose SCHEMBL20817160 | 0.81 | FDPS (0.39) | FDPSBTN3A1PDE3AKCNA5CYP19A1 | |
| SCHEMBL5897152 | 0.80 | PTPN1 (0.50) | FDPSBTN3A1PDE3ACYP2C9CYP2C19 | |
| SCHEMBL13746036 | 0.79 | FDPS (0.53) | FDPSBTN3A1PDE3AKCNA5CYP19A1 | |
| SCHEMBL8389732 | 0.79 | FDPS (0.46) | FDPSBTN3A1PDE3AKCNA5CYP19A1 | |
| SCHEMBL9602511 | 0.75 | FDPS (0.44) | FDPSBTN3A1PDE3AKCNA5CYP19A1 | |
| SCHEMBL4961800 | 0.75 | FDPS (0.51) | FDPSBTN3A1PDE3AKCNA5CYP19A1 | |
| SCHEMBL7763663 | 0.75 | KCNA5 (0.51) | FDPSBTN3A1PDE3AKCNA5CYP19A1 | |
| SCHEMBL9850885 | 0.74 | LMNA (0.51) | FDPSBTN3A1PDE3ACYP19A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008020305-A2 | SOLID DOSAGE FORMS OF BISPHOSPHONIC ACIDS | AUROBINDO PHARMA LIMITED (IN) | 2008-02-21 | — | — | WO | disclosed |
| EP-1476451-A1 | USE OF CERTAIN DILUENTS FOR MAKING BISPHOSPHONIC ACIDS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2004-11-17 | — | — | EP | disclosed |
| WO-2003097655-A1 | USE OF CERTAIN DILUENTS FOR MAKING BISPHOSPHONIC ACIDS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2003-11-27 | — | — | WO | disclosed |
| WO-1993013801-A1 | TREATMENT FOR ATHEROSCLEROSIS | THE PROCTER & GAMBLE COMPANY (US) | 1993-07-22 | — | — | WO | disclosed |